Effect of colpexin sphere on pelvic floor muscle strength in women with pelvic organ prolapse: A randomized controlled trial (a preliminary report)

Archives of Gynecology and Obstetrics

Volumn 283, Issue 3, 2011, Pages 575-579

  Harnsomboon, Thitima ^a   Manonai, Jittima ^a   Sarit Apirak, Sirirat ^b   Wattanayingcharoenchai, Rujira ^a   Chittacharoen, Apichart ^a   Sututvoravut, Somsak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Colpexin Sphere; Pelvic floor muscle strength; Pelvic organ prolapse

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEVICE; DISEASE CLASSIFICATION; FEMALE; HUMAN; MUSCLE CONTRACTION; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; PELVIC ORGAN PROLAPSE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

ADULT; BODY MASS INDEX; EXERCISE THERAPY; FEMALE; HUMANS; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PELVIC FLOOR; PELVIC ORGAN PROLAPSE; TREATMENT OUTCOME;

EID: 79951724926     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1394-4     Document Type: Article

References (12)

1. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A (2002) Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186:1160-1166 (Pubitemid 34665053)
2. Swift SE (2000) The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol 183:277-285
3. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J et al (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311-1316
4. Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KL (2008) Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 111:687-685
5. Meidel A, Tegerstedt G, Maehle-Schmidt M, Nyren O, Hammarstrom M (2009) Nonobstetrics risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol 113:1089-1097
6. Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK et al (2009) Racial differences in pelvic organ prolapse. Obstet Gynecol 114:1271-1277
7. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidermiology of surgically managed pelvic organ prolapse and urinary incomtinence. Obstet Gynecol 89:501-506 (Pubitemid 27133519)
8. Hagen S, Stark D, Maher C, Adams E (2006) Conservative management of pelvic organ prolapsed in women. Cochrane Database Syst Rev (4):CD003882
9. Adamkiewicz MM, Adamkiewicz MF, Jozwik M, Jozwik M (2001) Combined treatment of pelvic floor exercises and new intravaginal device for genital prolapse. Int Urogynecol J 12(Suppl 3):48
10. Lukban JC, Aguirre OA, Davila GW, Sand PK (2006) Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse. Int Urogynecol J 17:449-454 (Pubitemid 44138248)
11. Guerette N, Neimark M, Kopka SL, Jones JE, Davila GW (2004) Initial experience with a new method for the dynamic assessment of pelvic floor function in women; the Kolpexin Pull Test. Int Urogynecol J 15:39-43 (Pubitemid 38247932)
12. Brink CA, Sampselle CM, Wells TJ, Diokno AC, Gillis GL (1989) A digital test for pelvic muscle strength in older women with urinary incontinence. Nurs Res 38:196-199 (Pubitemid 19189128)